TruDataRx

The State of Connecticut has long been a leader in forward-thinking pharmacy plan management. The Connecticut Office of the State Comptroller has taken the next step toward achieving true lowest net-cost and--more importantly--highest clinical value in their pharmacy spend. #TruDataRx is honored to be working with the State to cover the best medicines for Connecticut's employees and their families. Chris Somers Levi Roseman Amelia Kirby Luca Fagotti Catalina Gorla https://lnkd.in/eYUZ4Wrp

We are honored to announce that our CEO and co-founder, Catalina Gorla, will be speaking at the International Society of Certified Employee Benefit Specialists #24SYMP. Come listen to Catalina on September 18 at 12pm in Nashville, and learn valuable insights on managing the cost of weight-loss drugs, and how to determine the most clinically valid coverage policies. Let us know if you'll be attending or in the area and would like to connect with Catalina! www.iscebs.org/symposium #SpeakerSpotlight #ExcitedToShare #CEBSgoals

It was truly a privilege to present alongside my dear colleague and client, Bill Spurgeon of the City of Newark, Ohio at #SALGBA this year in the great city of Louisville. Bill shared how with Comparative Effectiveness Research, we together achieved: 💊$2.5 million in savings, negative cost trend 💃60% cost reduction for members 🩺”The lives we protect are receiving more effective medications.” Chris Somers Levi Roseman Amelia Kirby Luca Fagotti TruDataRx

We are excited to announce that our CEO and co-founder, Catalina Gorla, will be presenting at SALGBA 2024 in Louisville, KY on 4/23 with our client Bill Spurgeon from the City of Newark. Learn how CER has helped the City of Newark reverse their Rx spend while continuing to cover the highest quality drugs. Let us know if you'll be attending or in the area and would like to connect with Catalina. #SALGBA2024 #CER #RXSpend

It's a great honor to be the recipient of the Traction Award for receiving the most matches during the Cohort 3 Summit of EHIR Innovation Roundtable, a World 50 Group Community Thanks so much to EHIR and the many employers who made this Summit a success! Catalina Gorla | Chris Somers | Jenna Lyall | Levi Roseman | Amelia Kirby | Luca Fagotti

TOMORROW 3/20: “I am at Risk. What the J&J Lawsuit Means and How to De-Risk Your Rx Benefits.” Join Chris Deacon and Catalina Gorla at 12:00 Noon EDT to dive into the details of the case, the risk facing employers, and what you can do to mitigate the risk. It’s not too late to register, so please consider signing up and telling your friends. Hope to see you soon! https://lnkd.in/eGvYEjqY

TOMORROW 3/20: “I am at Risk. What the J&J Lawsuit Means and How to De-Risk Your Rx Benefits.” Join Chris Deacon and Catalina Gorla at 12:00 Noon EDT to dive into the details of the case, the risk facing employers, and what you can do to mitigate the risk. It’s not too late to register, so please consider signing up and telling your friends. Hope to see you soon! https://lnkd.in/eGvYEjqY

Very much looking forward to doing this webinar together, Chris Deacon! As I've been traveling this month, many employers seem really interested in better understanding the J&J lawsuit and what it means for them. #pharmacybenefits #erisa

For self-insured employers, the talk about “potential” lawsuits is over – it’s here, and we’re all at risk. Please join us for a webinar exploring the implications for fiduciaries of the recent lawsuit against J&J. The suit claims Johnson & Johnson breached its fiduciary duty by failing to prudently manage its pharmacy benefit. Essentially, they traded control of their formulary for “guarantees” from conflicted entities. We’re honored to be partnering with Chris Deacon, JD, healthcare thought leader and former director of one of the largest self-funded health plans in the country for the State of New Jersey. In this webinar, you will learn:  - What the lawsuit is alleging - What this means for self-insured employers - Concrete steps you can do today to understanding your risk and exposure - How utilizing Comparative Effectiveness Research drives clinical value and reduces costs Please find more information and a registration link below. Wednesday March 20th 2024, 12 - 1pm ET https://lnkd.in/eGvYEjqY